M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyogenes isolate

M L Sanderson-Smith1, K Dinkla, J N Cole

  • 1School of Biological Sciences, University of Wollongong, Wollongong, NSW, 2522, Australia.

Insights

Group A Streptococcus (GAS) uses human plasmin to cause invasive disease. Blocking plasminogen binding to the M protein Prp significantly reduced GAS virulence in a mouse model.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Group A Streptococcus (GAS; Streptococcus pyogenes) is a significant human pathogen.
  • GAS causes invasive diseases, particularly in regions like Australia's Northern Territory.
  • The human protease plasmin is implicated in GAS pathogenesis.

Purpose of the Study:

  • To investigate the role of plasminogen binding by the GAS M protein Prp in virulence.
  • To determine how cell surface plasmin acquisition contributes to GAS invasive disease.

Main Methods:

  • Engineered an isogenic mutant (NS88.2prp) of GAS strain NS88.2 by altering key plasminogen-binding residues in the Prp protein.
  • Constructed a reverse complemented strain (NS88.2prpRC) with wild-type Prp sequence.
  • Assessed plasminogen binding and cell surface plasmin activity during growth in human plasma.
  • Evaluated GAS virulence using a humanized plasminogen mouse model of invasive infection.

Main Results:

  • The NS88.2prp mutant showed significantly reduced binding of human plasminogen compared to wild-type and NS88.2prpRC strains.
  • The mutant exhibited diminished accumulation of cell surface plasmin activity.
  • Impaired plasminogen binding and surface plasmin activity correlated with reduced GAS virulence in the mouse model.

Conclusions:

  • Plasminogen binding by the GAS M protein Prp is critical for acquiring cell surface plasmin activity.
  • This plasmin activity is essential for the virulence of Group A Streptococcus in invasive infections.

Related Concept Videos

Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...